# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 13, "Ophthalmology", "", "<http://ctro/data#Publication_96739> <http://ctro/data#hasJournal> \"Ophthalmology\"."
1, PublicationYear, 16, 20, "1996", "", "<http://ctro/data#Publication_96739> <http://ctro/data#hasPublicationYear> \"1996\"."
24, Title, 50, 186, "A six - month , randomized , double - masked study comparing latanoprost with timolol in open - angle glaucoma and ocular hypertension .", "", "<http://ctro/data#Publication_96739> <http://ctro/data#hasTitle> \"A six - month , randomized , double - masked study comparing latanoprost with timolol in open - angle glaucoma and ocular hypertension .\"."
106379, Duration, 52, 63, "six - month", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasCTduration> \"six - month\"."
3, Randomized, 66, 76, "randomized", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
4, DoubleBlind, 79, 94, "double - masked", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
5, Latanoprost, 111, 122, "latanoprost", "", 
6, Timolol, 128, 135, "timolol", "", 
7, OpenAngleGlaucoma, 139, 160, "open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
8, OcularHypertension, 165, 184, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
79, Latanoprost, 191, 202, "Latanoprost", "", 
106377, Author, 217, 225, "Watson P", "", "<http://ctro/data#Publication_96739> <http://ctro/data#hasAuthor> \"Watson P\"."
10, Author, 234, 249, "Stjernschantz J", "", "<http://ctro/data#Publication_96739> <http://ctro/data#hasAuthor> \"Stjernschantz J\"."
106378, UK, 318, 325, "England", "", "<http://ctro/data#Population_96769> <http://ctro/data#hasCountry> <http://ctro/data#UK>."
25, ObjectiveDescription, 338, 575, "To compare the intraocular pressure ( IOP ) - reducing effect and side effects of 0 . 005 % latanoprost administered once daily with 0 . 5 % timolol administered twice daily in patients with open - angle glaucoma or ocular hypertension .", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasObjectiveDescription> \"To compare the intraocular pressure ( IOP ) - reducing effect and side effects of 0 . 005 % latanoprost administered once daily with 0 . 5 % timolol administered twice daily in patients with open - angle glaucoma or ocular hypertension .\"."
12, IOP, 353, 373, "intraocular pressure", "", 
13, IOP, 376, 379, "IOP", "", 
14, DoseValue, 420, 427, "0 . 005", "", 
20, Percentage, 428, 429, "%", "", 
22, Latanoprost, 430, 441, "latanoprost", "", "<http://ctro/data#Latanoprost_97615> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_96822> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_97615>."
23, Frequency, 455, 465, "once daily", "", 
15, DoseValue, 471, 476, "0 . 5", "", 
21, Percentage, 477, 478, "%", "", 
16, Timolol, 479, 486, "timolol", "", 
17, Frequency, 500, 511, "twice daily", "", 
54362, Precondition, 515, 573, "patients with open - angle glaucoma or ocular hypertension", "", "<http://ctro/data#Population_96769> <http://ctro/data#hasPrecondition> \"patients with open - angle glaucoma or ocular hypertension\"."
18, OpenAngleGlaucoma, 529, 550, "open - angle glaucoma", "", 
19, OcularHypertension, 554, 573, "ocular hypertension", "", 
26, Randomized, 597, 607, "randomized", "", 
27, DoubleBlind, 610, 625, "double - masked", "", 
28, Parallel, 641, 649, "parallel", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
29, Duration, 683, 691, "6 months", "", 
34, ObjectiveDescription, 694, 852, "The primary objective of the study is to compare the IOP - reducing effect of lantanoprost with that of timolol at the end of the 6 - month treatment period .", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasObjectiveDescription> \"The primary objective of the study is to compare the IOP - reducing effect of lantanoprost with that of timolol at the end of the 6 - month treatment period .\"."
30, IOP, 747, 750, "IOP", "", 
31, Latanoprost, 772, 784, "lantanoprost", "", 
32, Timolol, 798, 805, "timolol", "", 
33, Duration, 824, 833, "6 - month", "", 
35, NumberPatientsCT, 864, 867, "294", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasNumberPatientsCT> \"294\"."
36, NumberPatientsArm, 893, 896, "149", "", "<http://ctro/data#Arm_96792> <http://ctro/data#hasNumberPatientsArm> \"149\"."
38, Latanoprost, 909, 920, "latanoprost", "", 
37, NumberPatientsArm, 931, 934, "145", "", "<http://ctro/data#Arm_96801> <http://ctro/data#hasNumberPatientsArm> \"145\"."
39, Timolol, 943, 950, "timolol", "", 
40, Latanoprost, 959, 970, "Latanoprost", "", 
54045, Evening, 995, 1002, "evening", "", 
41, Diurnal_IOP, 1015, 1026, "Diurnal IOP", "", "<http://ctro/data#Endpoint_96777> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
42, TimePoint, 1029, 1038, "9 : 00 am", "", 
43, TimePoint, 1041, 1050, "1 : 00 pm", "", 
44, TimePoint, 1053, 1062, "5 : 00 pm", "", 
45, BaseLineValue, 1082, 1088, "25 . 2", "", "<http://ctro/data#Outcome_96836> <http://ctro/data#hasBaselineValue> \"25 . 2\"."
46, ResultMeasuredValue, 1092, 1098, "16 . 7", "", "<http://ctro/data#Outcome_96836> <http://ctro/data#hasResultMeasuredValue> \"16 . 7\"."
47, mmHg, 1099, 1103, "mmHg", "", "<http://ctro/data#Endpoint_96777> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
48, RelativeReduction, 1106, 1112, "33 . 7", "", "<http://ctro/data#Outcome_96836> <http://ctro/data#hasRelativeChangeValue> \"33 . 7\"."
49, Latanoprost, 1122, 1134, "lantanoprost", "", 
50, BaseLineValue, 1144, 1150, "25 . 4", "", "<http://ctro/data#Outcome_96863> <http://ctro/data#hasBaselineValue> \"25 . 4\"."
51, ResultMeasuredValue, 1154, 1160, "17 . 1", "", "<http://ctro/data#Outcome_96863> <http://ctro/data#hasResultMeasuredValue> \"17 . 1\"."
52, mmHg, 1161, 1165, "mmHg", "", 
53, RelativeReduction, 1168, 1174, "32 . 7", "", "<http://ctro/data#Outcome_96863> <http://ctro/data#hasRelativeChangeValue> \"32 . 7\"."
54, Timolol, 1184, 1191, "timolol", "", 
55, Duration, 1224, 1233, "6 - month", "", 
57, ObservedResult, 1253, 1331, "No upward drift in IOP occurred with either drug during the treatment period .", "", 
56, IOP, 1272, 1275, "IOP", "", 
58, Latanoprost, 1332, 1343, "Latanoprost", "", 
60, ObservedResult, 1332, 1451, "Latanoprost caused a somewhat more conjunctival hyperemia than timolol and more corneal punctuate epithelial erosions .", "", "<http://ctro/data#Outcome_96890> <http://ctro/data#hasObservedResult> \"Latanoprost caused a somewhat more conjunctival hyperemia than timolol and more corneal punctuate epithelial erosions .\". <http://ctro/data#Outcome_96951> <http://ctro/data#hasObservedResult> \"Latanoprost caused a somewhat more conjunctival hyperemia than timolol and more corneal punctuate epithelial erosions .\"."
136, ConjunctivalHyperemia, 1367, 1389, "conjunctival hyperemia", "", "<http://ctro/data#Endpoint_96782> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#ConjunctivalHyperemia>."
59, Timolol, 1395, 1402, "timolol", "", 
106371, Corneal_PPE, 1412, 1449, "corneal punctuate epithelial erosions", "", "<http://ctro/data#Endpoint_96946> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Corneal_PPE>."
61, ObservedResult, 1462, 1504, "both drugs were generally well tolerated .", "", 
62, Latanoprost, 1541, 1552, "latanoprost", "", 
140, IrisPigmentation, 1567, 1591, "pigmentation of the iris", "", "<http://ctro/data#IrisPigmentation_96788> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IrisPigmentation>. <http://ctro/data#Endpoint_96787> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IrisPigmentation_96788>."
63, NumberAffected, 1614, 1616, "15", "", "<http://ctro/data#Outcome_96917> <http://ctro/data#hasNumberAffected> \"15\"."
64, PercentageAffected, 1628, 1634, "10 . 1", "", "<http://ctro/data#Outcome_96917> <http://ctro/data#hasPercentageAffected> \"10 . 1\"."
65, Timolol, 1641, 1648, "Timolol", "", 
66, Latanoprost, 1688, 1699, "latanoprost", "", 
145, ConclusionComment, 1716, 1851, "Latanoprost 0 . 005 % administered once daily in the evening reduced IOP at least as well as timolol 0 . 5 % administered twice daily .", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasConclusionComment> \"Latanoprost 0 . 005 % administered once daily in the evening reduced IOP at least as well as timolol 0 . 5 % administered twice daily .\"."
67, Latanoprost, 1716, 1727, "Latanoprost", "", 
68, DoseValue, 1728, 1735, "0 . 005", "", "<http://ctro/data#Medication_96822> <http://ctro/data#hasDoseValue> \"0 . 005\"."
70, Percentage, 1736, 1737, "%", "", "<http://ctro/data#Medication_96822> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
72, Frequency, 1751, 1761, "once daily", "", "<http://ctro/data#Intervention_96810> <http://ctro/data#hasFrequency> \"once daily\"."
54048, Evening, 1769, 1776, "evening", "", "<http://ctro/data#Intervention_96810> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Evening>."
154, IOP, 1785, 1788, "IOP", "", 
75, Timolol, 1809, 1816, "timolol", "", "<http://ctro/data#Medication_96829> <http://ctro/data#hasDrug> <http://ctro/data#Timolol>."
69, DoseValue, 1817, 1822, "0 . 5", "", "<http://ctro/data#Medication_96829> <http://ctro/data#hasDoseValue> \"0 . 5\"."
71, Percentage, 1823, 1824, "%", "", "<http://ctro/data#Medication_96829> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
73, Frequency, 1838, 1849, "twice daily", "", "<http://ctro/data#Intervention_96816> <http://ctro/data#hasFrequency> \"twice daily\"."
146, ConclusionComment, 1852, 1922, "Latanoprost was generally well tolerated systemically and in the eye .", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasConclusionComment> \"Latanoprost was generally well tolerated systemically and in the eye .\"."
76, Latanoprost, 1852, 1863, "Latanoprost", "", 
147, ConclusionComment, 1923, 2083, "However , the drug has an unusual side effect of increasing the pigmentation of the iris , particularly in individuals with green - brown or blue - brown eyes .", "", "<http://ctro/data#ClinicalTrial_96747> <http://ctro/data#hasConclusionComment> \"However , the drug has an unusual side effect of increasing the pigmentation of the iris , particularly in individuals with green - brown or blue - brown eyes .\"."
160, IrisPigmentation, 1987, 2011, "pigmentation of the iris", "", 
80, PMID, 2091, 2098, "8628543", "", "<http://ctro/data#Publication_96739> <http://ctro/data#hasPMID> \"8628543\"."
